Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 29;14(1):44.
doi: 10.1186/s13613-024-01270-w.

Clinical description and outcome of overall varicella-zoster virus-related organ dysfunctions admitted in intensive care units: the VAZOREA cohort study

Affiliations

Clinical description and outcome of overall varicella-zoster virus-related organ dysfunctions admitted in intensive care units: the VAZOREA cohort study

Jolan Malherbe et al. Ann Intensive Care. .

Abstract

Background: Due to aging population and increasing part of immunocompromised patients, a raise in life-threatening organ damage related to VZV can be expected. Two retrospective studies were already conducted on VZV in ICU but focused on specific organ injury. Patients with high-risk of VZV disease still must be identified. The objective of this study was to report the clinical features and outcome of all life-threatening VZV manifestations requiring intensive care unit (ICU) admission. This retrospective cohort study was conducted in 26 French ICUs and included all adult patients with any life-threatening VZV-related event requiring ICU admission or occurring in ICU between 2010 and 2019.

Results: One-hundred nineteen patients were included with a median SOFA score of 6. One hundred eight patients (90.8%) were admitted in ICU for VZV disease, leaving 11 (9.2%) with VZV disease occurring in ICU. Sixty-one patients (51.3%) were immunocompromised. Encephalitis was the most prominent organ involvement (55.5%), followed by pneumonia (44.5%) and hepatitis (9.2%). Fifty-four patients (45.4%) received norepinephrine, 72 (60.5% of the total cohort) needed invasive mechanical ventilation, and 31 (26.3%) received renal-replacement therapy. In-hospital mortality was 36.1% and was significantly associated with three independent risk factors by multivariable logistic regression: immunosuppression, VZV disease occurring in ICU and alcohol abuse. Hierarchical clustering on principal components revealed five phenotypically distinct clusters of patients: VZV-related pneumonia, mild encephalitis, severe encephalitis in solid organ transplant recipients, encephalitis in other immunocompromised hosts and VZV disease occurring in ICU. In-hospital mortality was highly different across phenotypes, ranging from zero to 75% (p < 0.001).

Conclusion: Overall, severe VZV manifestations are associated with high mortality in the ICU, which appears to be driven by immunosuppression status rather than any specific organ involvement. Deciphering the clinical phenotypes may help clinicians identify high-risk patients and assess prognosis.

Keywords: Encephalitis; Immunocompromised host; Intensive care units; Pneumonia; Varicella-Zoster virus.

PubMed Disclaimer

Conflict of interest statement

The present authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Factorial plan of hierarchical classification on principal components These first two dimensions summarize 20.8% of the data variability. The five clusters are represented with different colours. Black dots represent patients with mild encephalitis, red dots are for VZV-related pneumonia, green dots for severe encephalitis in immunocompromised patients, blue dots for VZV-disease occurring in ICU, and turquoise for severe encephalitis in solid organ transplant recipients

References

    1. Heininger U, Seward JF, Varicella Lancet. 2006;368:1365–76. doi: 10.1016/S0140-6736(06)69561-5. - DOI - PubMed
    1. Gnann JW, Whitley RJ. Herpes zoster. N Engl J Med. 2002;347:340–6. doi: 10.1056/NEJMcp013211. - DOI - PubMed
    1. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D et al. Varicella zoster virus infection. Nature Reviews Disease Primers [Internet]. 2015 [cited 2020 Jan 15];1. Available from: http://www.nature.com/articles/nrdp201516. - PMC - PubMed
    1. Heininger U, Braun-Fahrländer C, Desgrandchamps D, Glaus J, Grize L, Wutzler P et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity: the Pediatric Infectious. Disease J. 2001;775–8. - PubMed
    1. Wiese-Posselt M, Siedler A, Mankertz A, Sauerbrei A, Hengel H, Wichmann O, et al. Varicella-Zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany. BMC Infect Dis. 2017;17:356. doi: 10.1186/s12879-017-2461-2. - DOI - PMC - PubMed

LinkOut - more resources